The FDA has approved zongertinib for patients with unresectable or metastatic non-squamous non-small cell lung cancer that has HER2 tyrosine kinase domain mutations and has undergone prior treatment. The U.S. Food and Drug Administration...
The FDA has approved the first-in-class therapeutic dordaviprone for certain adult and pediatric patients with H3 K27M-mutated diffuse midline glioma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to dordaviprone (Modeyso)...
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.
Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
Most liver cancers can be prevented, and a common type of HPV is linked to skin cancer.
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
Doctors often don’t discuss sexual side effects with breast cancer survivors, and cardiac biomarkers may indicate increased risk for certain cancers.
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise of early-onset cancers.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More